Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine? [5]

JAMA

Volumn 283, Issue 14, 2000, Pages 1826-1827

  MacDonald, Noni E ^a   Halperin, Scott A ^a   Law, Barbara J ^b   Danzig, Lisa E ^c   Granoff, Dan M ^d  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c NOVARTIS PHARMA AG   (Switzerland)

^d CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ANTIBODY RESPONSE; CHILD; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; INFECTION RISK; LETTER; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL;

EID: 0034639972     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.14.1826     Document Type: Letter

References (3)